Decision‐Making on First‐Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi‐Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy

Paolo Sportoletti, Felice Bombaci, Chiara Cernetti, Alessandra Di Costanzo, Francesca Fiorentino, Sara Manurita, Andrea Marcellusi, Riccardo Mercati, Massimo Riccaboni, Chiara Vassallo, Antonio Cuneo

Open source

DOI
10.1002/hon.70274
Published
2026-11
Container
Hematological Oncology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hon.70274,
  title = {Decision‐Making on First‐Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi‐Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy},
  author = {Paolo Sportoletti and Felice Bombaci and Chiara Cernetti and Alessandra Di Costanzo and Francesca Fiorentino and Sara Manurita and Andrea Marcellusi and Riccardo Mercati and Massimo Riccaboni and Chiara Vassallo and Antonio Cuneo},
  year = {2026},
  journal = {Hematological Oncology},
  doi = {10.1002/hon.70274},
  url = {https://doi.org/10.1002/hon.70274}
}

RIS

TY  - JOUR
TI  - Decision‐Making on First‐Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi‐Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy
AU  - Paolo Sportoletti
AU  - Felice Bombaci
AU  - Chiara Cernetti
AU  - Alessandra Di Costanzo
AU  - Francesca Fiorentino
AU  - Sara Manurita
AU  - Andrea Marcellusi
AU  - Riccardo Mercati
AU  - Massimo Riccaboni
AU  - Chiara Vassallo
AU  - Antonio Cuneo
PY  - 2026
JO  - Hematological Oncology
DO  - 10.1002/hon.70274
UR  - https://doi.org/10.1002/hon.70274
ER  - 

APA

Sportoletti, P., Bombaci, F., Cernetti, C., Costanzo, A. D., Fiorentino, F., Manurita, S., Marcellusi, A., Mercati, R., Riccaboni, M., Vassallo, C., & Cuneo, A. (2026). Decision‐Making on First‐Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi‐Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy. Hematological Oncology. https://doi.org/10.1002/hon.70274

Source records